Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Volume: 381, Issue: 4, Pages: 317 - 327
Published: Jun 2, 2019
Abstract
Background Patients with a germline BRCA1 or BRCA2 mutation make up a small subgroup of those with metastatic pancreatic cancer. The poly(adenosine diphosphate–ribose) polymerase (PARP)...
Paper Details
Title
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Published Date
Jun 2, 2019
Volume
381
Issue
4
Pages
317 - 327
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.